SBTX
NEUTRALSkinBioTherapeutics Provides Update on Croda Commercial Launch
The life science company reports that the commercialisation of its product with Croda is progressing as expected, though financial details remain confidential.
SkinBioTherapeutics
16.50GBX
1.54%
Market Cap
43.68M
Volume
674.7k
47% of avg
P/E Ratio
-0.24
EPS (TTM)
-0.7
Beta
0.76
Day Range
16.26p - 16.60p
52 Week Range
8.50p16.50p27.50p
16.50p
Upcoming Events
Early September 2025
Initial roll-out of AxisBiotix products in Superdrug stores
High Impact Event
Early Q1 2026
Phased roll-out of AxisBiotix products to rest of Superdrug's UK store portfolio
High Impact Event
SBTX
NEUTRALSkinBioTherapeutics Announces Superdrug Commercial Agreement
The life science company has signed an exclusive UK commercial agreement with Superdrug Stores to sell its AxisBiotix™ food supplements.
SBTX
NEUTRALSkinBioTherapeutics Announces Holding Change
The healthcare company has announced a change in shareholding, with an investor increasing their stake in the business.
SBTX
NEUTRALSkinBioTherapeutics Completes WRAP Retail Offer
The life science group has completed a retail offering, raising £0.1 million.
SBTX
GOODSkinBioTherapeutics Announces £0.62m Retail Offer
The healthcare company is raising up to £0.62m through a retail offer, with the new shares priced at a small premium to the previous closing price.
SBTX
NEUTRALSkinBioTherapeutics signs exclusive deal with Superdrug, raises £4.1m
The healthcare company has signed an exclusive UK deal with a major retailer and raised funds to support the launch and product development.
SBTX
NEUTRALSkinBioTherapeutics Appoints New Nominated Adviser and Broker
The life science company has appointed a new nominated adviser and sole broker.
SBTX
NEUTRALSkinBioTherapeutics Appoints New Nominated Adviser and Broker
The life science company has appointed a new Nominated Adviser and Sole Broker.
SBTX
NEUTRALSkinBioTherapeutics Announces Director Dealings
The healthcare company has announced changes to its major shareholdings.
SBTX
NEUTRALSkinBioTherapeutics Announces Holding Change
The healthcare company has announced a change in its major shareholding, with Optibiotix Health plc reducing its stake in the business.